Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Learn about groundbreaking developments in bladder cancer diagnostics through this 31-minute webinar presented by Dr. Charles J. Rosser, a distinguished physician-scientist and Professor of Surgery at Cedars Sinai Medical Center. Explore an innovative multiplex immunoassay designed to address critical challenges in bladder cancer detection and treatment monitoring. Discover how this novel test aims to improve the evaluation of hematuria, which affects up to 10% of the general population and serves as an initial indicator of bladder cancer. Gain insights into the management of non-muscle-invasive bladder cancer (NMIBC), its high recurrence rates, and the challenges of BCG treatment response prediction. Understand the potential impact of this diagnostic advancement on patient care, particularly in ensuring timely and appropriate treatment decisions for those at risk of progression to muscle invasive bladder cancer (MIBC).
